BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

TEVA upcoming catalysts

TEVA: 0 upcoming industry Phase 2/3 trial readout(s) in the next 90 days (0 Phase 3), 0 upcoming FDA decision event(s), and in the last 12 months 0 readout(s) and 5 FDA event(s). Subscribe to TEVA (.ics).

Upcoming FDA decision events

DateEventStatusCompanyDrugSource
No upcoming PDUFA date or AdCom found.

Upcoming trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
No trials in this window.

FDA decision events, last 12 months

DateEventStatusCompanyDrugSource
2026-11-13FDA approvalapprovedTEVA TEVAIGALMIApproved 2026-11-13: IGALMI (NDA215390 SUPPL3)
2026-10-08FDA approvalapprovedTEVA TEVAWELTRUZAApproved 2026-10-08: WELTRUZA (NDA219007 ORIG1)
2026-09-25FDA approvalapprovedTEVA PHARMACEUTICALS, INC. TEVADEGEVMAApproved 2026-09-25: DEGEVMA (BLA761481 ORIG1)
2026-03-27FDA approvalapprovedTEVA PHARMACEUTICALS, INC. TEVAPONLIMSIApproved 2026-03-27: PONLIMSI (BLA761385 ORIG1)
2025-11-19FDA approvalapprovedTEVA TEVAIGALMIApproved 2025-11-19: IGALMI (NDA215390 SUPPL2)

Trial readouts, last 12 months

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
No readouts in the last 12 months.

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.